Context Therapeutics - 3 Year Stock Price History | CNTX

The latest closing stock price for Context Therapeutics as of November 21, 2024 is 1.50.

  • An investor who bought $1,000 worth of Context Therapeutics stock at the IPO in 2021 would have $-706 today, roughly -1 times their original investment - a -33.50% compound annual growth rate over 3 years.
  • The all-time high Context Therapeutics stock closing price was 7.45 on October 25, 2021.
  • The Context Therapeutics 52-week high stock price is 2.75, which is 83.3% above the current share price.
  • The Context Therapeutics 52-week low stock price is 0.77, which is 48.7% below the current share price.
  • The average Context Therapeutics stock price for the last 52 weeks is 1.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

Context Therapeutics - 3 Year Stock Price History | CNTX

  • An investor who bought $1,000 worth of Context Therapeutics stock at the IPO in 2021 would have $-706 today, roughly -1 times their original investment - a -33.50% compound annual growth rate over 3 years.
  • The all-time high Context Therapeutics stock closing price was 7.45 on October 25, 2021.
  • The Context Therapeutics 52-week high stock price is 2.75, which is 83.3% above the current share price.
  • The Context Therapeutics 52-week low stock price is 0.77, which is 48.7% below the current share price.
  • The average Context Therapeutics stock price for the last 52 weeks is 1.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.